| Role of phytochemicals in cancer prevention A Ranjan, S Ramachandran, N Gupta, I Kaushik, S Wright, S Srivastava, ... International journal of molecular sciences 20 (20), 4981, 2019 | 287 | 2019 |
| Cancer cells stemness: A doorstep to targeted therapy S Prasad, S Ramachandran, N Gupta, I Kaushik, SK Srivastava Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (4), 165424, 2020 | 115 | 2020 |
| Free radicals as a double-edged sword: The cancer preventive and therapeutic roles of curcumin N Gupta, K Verma, S Nalla, A Kulshreshtha, R Lall, S Prasad Molecules 25 (22), 5390, 2020 | 102 | 2020 |
| Role of Forkhead Box Class O proteins in cancer progression and metastasis CG Kim, H Lee, N Gupta, S Ramachandran, I Kaushik, S Srivastava, ... Seminars in cancer biology 50, 142-151, 2018 | 96 | 2018 |
| Selective AKR1C3 inhibitors potentiate chemotherapeutic activity in multiple acute myeloid leukemia (AML) cell lines K Verma, T Zang, N Gupta, TM Penning, PC Trippier ACS medicinal chemistry letters 7 (8), 774-779, 2016 | 46 | 2016 |
| Penfluridol overcomes paclitaxel resistance in metastatic breast cancer N Gupta, P Gupta, SK Srivastava Scientific reports 9 (1), 5066, 2019 | 43 | 2019 |
| AKR1C3 inhibitor KV-37 exhibits antineoplastic effects and potentiates enzalutamide in combination therapy in prostate adenocarcinoma cells K Verma, N Gupta, T Zang, P Wangtrakluldee, SK Srivastava, TM Penning, ... Molecular cancer therapeutics 17 (9), 1833-1845, 2018 | 43 | 2018 |
| HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells P Gupta, N Gupta, NM Fofaria, A Ranjan, SK Srivastava Cancer letters 442, 68-81, 2019 | 36 | 2019 |
| Atovaquone: an antiprotozoal drug suppresses primary and resistant breast tumor growth by inhibiting HER2/β-catenin signaling N Gupta, SK Srivastava Molecular cancer therapeutics 18 (10), 1708-1720, 2019 | 31 | 2019 |
| Atovaquone suppresses triple-negative breast tumor growth by reducing immune-suppressive cells N Gupta, S Gaikwad, I Kaushik, SE Wright, MM Markiewski, SK Srivastava International Journal of Molecular Sciences 22 (10), 5150, 2021 | 26 | 2021 |
| Low dose of penfluridol inhibits VEGF-induced angiogenesis S Srivastava, FT Zahra, N Gupta, PE Tullar, SK Srivastava, CM Mikelis International Journal of Molecular Sciences 21 (3), 755, 2020 | 14 | 2020 |
| Atovaquone suppresses the growth of metastatic triple-negative breast tumors in lungs and brain by inhibiting integrin/FAK signaling axis N Gupta, SK Srivastava Pharmaceuticals 14 (6), 521, 2021 | 9 | 2021 |
| The CIC-ERF co-deletion underlies fusion-independent activation of ETS family member, ETV1, to drive prostate cancer progression N Gupta, H Song, W Wu, RK Ponce, YK Lin, JW Kim, EJ Small, FY Feng, ... Elife 11, e77072, 2022 | 6 | 2022 |
| Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer JW Kim, C Luck, W Wu, RK Ponce, YK Lin, N Gupta, RA Okimoto Cell reports 41 (1), 2022 | 6 | 2022 |
| Oxidative stress by proguanil suppresses breast tumor growth N Gupta, S Srivastava Cancer Research 79 (13_Supplement), 4795-4795, 2019 | | 2019 |
| The anti-protozoal drug Atovaquone suppresses the metastasis of triple negative breast tumors to brain, lungs and liver by inhibiting integrin-src pathway N Gupta, S Srivastava Cancer Research 79 (13_Supplement), 1238-1238, 2019 | | 2019 |
| Antimetastatic potential of Atovaquone against triple negative breast cancer: Involvement of the integrin‐FAK‐Src pathway N Gupta, S Srivastava The FASEB Journal 33 (S1), 647.9-647.9, 2019 | | 2019 |
| Repurposing atovaquone, an antiprotozoal drug for management of breast cancer by inhibiting HER2/β-catenin signaling N Gupta, S Srivastava Cancer Research 78 (13_Supplement), 2883-2883, 2018 | | 2018 |
| Diterpenoid pseudolaric acid B induces M-phase arrest and apoptosis primarily through JNK stress signaling in LNCaP prostate cancer cells KC Pramanik, N Gupta, M Ye, J Lu, C Jiang Cancer Research 78 (13_Supplement), 271-271, 2018 | | 2018 |
| Abstract LB-125: Atovaquone suppresses triple negative breast tumor growth by inhibiting myeloid derived suppressor cells N Gupta, S Wright, S Srivastava Cancer Research 78 (13_Supplement), LB-125-LB-125, 2018 | | 2018 |
Sanjay SrivastavaVerified email at ttuhsc.edu
